Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A budget review helps you spot gaps and realign spending with goals. This introduction highlights essential items to include for a clear, actionable assessment.
17,603 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This year’s Federal Reserve stress tests delivered a standout message: America’s banks are sturdier than ever. All ma...
Carnival stock moved sharply this week after a mixed update. Here are three burning questions investors should consid...
Investors are weighing XRP's future over a three-year horizon. This article lays out a realistic outlook, three scena...
A widower's online romance ended in a devastating financial hit. Learn how romance scams work, red flags to spot, and...
A common retirement scenario shows delaying benefits could turn a $1,800 monthly Social Security check into $2,232 by...
AI-driven improvements are speeding mortgage processing, yet governance gaps loom. This piece examines the drive, ris...
Twilio stocks have seen a pullback after a strong run. This guide explains how to assess whether you should twilio di...
The Magnificent Seven have steered the market for years. This guide explains how to determine which stock among them ...
Retail traders who chased celebrity-backed crypto deals tied to a high-profile political name are confronting losses ...
Owens Corning stock rocked the market this week after rumor-driven buying interest and strong housing data. This guid...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...